Results 231 to 240 of about 2,058,753 (356)

Cellular and Molecular Biomarkers Indicate Precocious in vitro Senescence in Fibroblasts From SAMP6 Mice: Evidence Supporting a Murine Model of Premature Senescence and Osteopenia

, 1997
Beata Lecka‐Czernik, Elena J. Moerman, Robert J. Shmookler Reis, David A. Lipschitz   +3 more
openalex   +1 more source

Evaluation of stress-inducible hsp90 gene expression as a potential molecular biomarker in Xenopus laevis [PDF]

, 1996
Adnan Hussein Ali, P.H. Krone, Derek Pearson, John J. Heikkila   +3 more
openalex   +1 more source

The MSA Atrophy Index (MSA‐AI): An Imaging Marker for Diagnosis and Clinical Progression in Multiple System Atrophy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Reliable biomarkers are essential for tracking disease progression and advancing treatments for multiple system atrophy (MSA). In this study, we propose the MSA Atrophy Index (MSA‐AI), a novel composite volumetric measure to distinguish MSA from related disorders and monitor disease progression. Methods Seventeen participants with an
Paula Trujillo, Kilian Hett, Amy Cooper, Amy E. Brown, Jessica Iregui, Manus J. Donahue, M. Erik Landman, Italo Biaggioni, Margaret Bradbury, Cynthia Wong, David Stamler, Daniel O. Claassen   +11 more
wiley   +1 more source

Prognostic Potential of Candidate miRNAs in Lung Cancer: Insights from Tissue and Liquid Biopsies

The Journal of Liquid Biopsy, 2023
A. Garcia, O. Vera, D. Sanchez-Cabrero, L. Gutierrez, O. Higueras, I. Esteban, C. Rodriguez-Antolín, I. Losantos, J. De Castro, I. Ibanez De Caceres   +9 more
doaj  

Identification of potential biomarkers and mechanisms for keloid disorder based on comprehensive bioinformatics analysis and machine learning algorithms. [PDF]

BMC Med Genomics
Zheng B, Qiao J, Yu X, Zhou H, Wang A, Zhang X.   +5 more
europepmc   +1 more source

Reply to Letter: Real‐World Clinical Experience With Serum MOG and AQP4 Antibody Testing by Live Versus Fixed Cell‐Based Assay

Annals of Clinical and Translational Neurology, EarlyView.
Yana Said, Conlan Tran, LuAnn Rezavi, Patrizio Caturegli, Eoin P. Flanagan, Elias S. Sotirchos   +5 more
wiley   +1 more source

Performance of Composite Endpoints Defining Progression Independent of Relapse Activity in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The characteristics and utility of composite progression independent of relapse activity (cPIRA; worsening on the Expanded Disability Status Scale [EDSS], or 9‐Hole Peg Test, or Timed 25‐Foot Walk Test) were evaluated as an endpoint in relapsing multiple sclerosis (RMS) trials using the ENSEMBLE (NCT03085810) and pooled OPERA I/II ...
Ludwig Kappos, Sean Yiu, Jason Reucassel, Jiwon Oh, Cristina Granziera, Joep Killestein, Robert A. Bermel, Claude Berge, Agne Kazlauskaite, Hans‐Martin Schneble, Frank Dahlke, Bruce A. C. Cree   +11 more
wiley   +1 more source

The current state of imaging biomarker development and evaluation. [PDF]

Br J Radiol
Halligan S, Mallett S.
europepmc   +1 more source

Commentary: Biomarker Strategies to Evaluate the Environmental Effects of Chemicals

, 1998
C.H. Walker
openalex   +1 more source

Fixel‐Based Analysis of Diffusion Imaging as a Quantitative Marker of Disease State in Spinocerebellar Ataxia

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Spinocerebellar ataxias (SCAs) are a group of genetically heterogeneous neurodegenerative diseases causing progressive deterioration and reduced quality of life. Therapeutic advances have been limited by a lack of sensitive anatomic, functional, or diffusion imaging‐based biomarkers.
David J. Arpin, S. H. Subramony, the READISCA Consortium, David E. Vaillancourt, Tetsuo Ashizawa, Alexandra Durr, Thomas Mareci, Thomas Klockgether, Jennifer Faber, Henry L. Paulson, Gülin Öz, Matthew R. Burns   +11 more
wiley   +1 more source